Vitae Pharmaceuticals, Inc 4
4 · Vitae Pharmaceuticals, Inc · Filed Feb 16, 2016
Insider Transaction Report
Form 4
Fratamico Arthur
Chief Business Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2016-02-15+19,250→ 19,250 totalExercise: $8.58Exp: 2026-02-15→ Common Stock (19,250 underlying)
Footnotes (1)
- [F1]This option shall vest with respect to 25% of the shares of stock which are subject to this option on February 15, 2017 (the "Initial Vesting Date") and 1/48th of the shares of stock which are subject to this option monthly following the Initial Vesting Date.